GlassScriptPhysician profile
Glen Diacon
NPI 1588659957
$2,178.15
in general payments reported to CMS, 2019-2025
25 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $311 · 2021: $392 · 2022: $515 · 2023: $226 · 2024: $333 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $420.12 | 2020-2025 | Myrisk, Prolaris |
| Medtronic, INC. | $256.25 | 2021-2024 | Interstim |
| Boston Scientific Corporation | $188.47 | 2019-2025 | Bulkamid, Axonics |
| Teleflex LLC | $146.42 | 2022 | |
| Coloplast Corp | $135.06 | 2019-2025 | Coloplast Tfl Drive |
| Astellas Pharma US INC | $133.84 | 2019-2025 | Xtandi |
| Abbvie INC. | $106.70 | 2020-2023 | Lupron Depot |
| Medtronic USA, INC. | $88.39 | 2019-2020 | |
| Myovant Sciences INC. | $82.82 | 2021 | |
| Healthtronics Stone Solutions, LLC | $72.19 | 2019-2021 | |
| Pfizer INC. | $71.93 | 2020-2025 | |
| Depuy Synthes Sales INC. | $67.24 | 2025 | Dynacord, Quickanchor Orthocord |
| Janssen Biotech, INC. | $56.28 | 2019-2023 | Erleada |
| Urogen Pharma, INC. | $54.04 | 2022-2025 | |
| Axonics, INC. | $49.66 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $44.76 | 2023 | Gemtesa |
| Urovant Sciences INC | $42.22 | 2022 | |
| Stryker Corporation | $38.89 | 2022 | |
| Caldera Medical, INC | $26.61 | 2021-2022 | |
| Travere Therapeutics, INC. | $22.84 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $17.02 | 2020 | |
| Blue Earth Diagnostics | $15.09 | 2020 | |
| Antares Pharma, INC. | $14.12 | 2022 | |
| Aytu Biopharma, INC. | $13.85 | 2019 | |
| Galderma Laboratories, L.P. | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glen Diacon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.